Список цитируемой и рекомендуемой литературы
Кортикостероиды
Boylan J. J., Owen D. S., Chin J. B. Phenytoin interference with dexamethasone. — J. A. M. A., 1976, 235* 803,
Brooks S. M., Werk E. E., Ackerman S. J. Irene and Thrasher, Katherine: Adverse effects of phenobarbital on corticosteroid metabolism in asthmatics. — New Engl. J. Med., 1972, 286, 1125.
Buffington G. A., Dominguez H. H., Piering W. F. et al. Interaction of rifampicin and glucocorticoids. — J. A. M. A., 1976, 236, 1958.
Caruso I., Porro G. B. Gastroscopic evaluation of anti-inflammatory agents. — Brit. med. J., 1979, 280, 75.
Choi Y., Thrasher K., Werk E. E. Effect of diphenylhydantoin on Cortisol kinetics in humans. — J. Pharmacol. Exp. Therapeutics, 1971, 176, 27.
David D. S„ Grieco M. H., Cushman P. Adrenal glucocorticoids after twenty years. A review of their clinically relevant consequences. — J. chron. Dis., 1971, 22, 637.
Dujovne C. A., Azarnoff D. L. In Azarnoff (Ed.) Steroid Therapy, p. 27. Saunders, Philadelphia, 1975.
Dubois E. L. Lupus Erythematosus, 2nd ed. p. 163. University of Southern California Press. Los Angeles, 1974.
Eckler E., Schonberg D., Bierich J. B. Monatsschrift fur Kinderheilkunde, 1966, 114, 271.
Edwards O. M., Courtenay-Evans R. J., Galley J. M. et al. Changes in Cortisol metabolism following rifampicin therapy. — Lancet, 1974, 2, 549.
Flo man Y., Zor U. Mechanism of steroid action in inflammation; inhibition of prostaglandin synthesis and release. — Prostaglandins, 1976, 12, 403.
Graham G. G., Champion G. D., Day R. O., Paull P. D. Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis. — Clin. Pharmacol. Therapeutics, 1977, 22, 410.
Grant S. D., Forsham P. H., Diraimondo V. C. Suppression of 17-hydroxycorti-costeroids in plasma and urine by single and divided doses of triamcinolone. — New Engl. J. Med., 1965, 273, 1115.
Gryglewski R. J., Panczenko В., Korbut R. et al. Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lings of sensitised guinea pig. — Prostaglandins, 1975, 10, 343.
Haque N., Thrasher K., Werk E. E. et al. Studies on dexamethasone metabolism in man effect of diphenylhydantom. — J. clin. Endocrinol. Metabol., 1972, 34, 44.
Hart F. D. Complicated rheumatoid disease. — Brit. med. J., 1966, 2, 131.
Hart F. D. In: Organic Manifestation and Complications in Rheumatoid Arthritis, p. 314. Schattauer Verlag, Stuttgart, 1976.
Harvey A. M., Shulman L. E., Tumulty P. A. et al. Systemic lupus erythematosus: Review of the literature and clinical analysis of 138 cases. — Medicine (Baltimore), 1954, 33, 291.
Haynes R. C, Lamer J. In: Goodman and Gilman (Eds.) The Pharmacological Basis of Therapeutics, 5th ed. p. 1488. Macmillan. New York, 1975.
Haynes R. C. In Azarnoff (Ed.) Steroid Therapy, p. 19. Saunders, Philadelphia, 1975.
Hughes G. R. V. Systemic (disseminated) lupus erythematosus. Report on Rheumatic Diseases No 72. Arthritis and Rheumatism Council, 1980.
Kantrowitz F., Robinson D. R., McGuire M. B. et al. Corticosteroids inhibit prostaglandin production by rheumatoid synovia. — Nature, 1975, 258, 737.
Kemper J. W., Baggenstoss A. H., Slocumb С. H. The relationship of therapy with cortisone to the incidence of vascular lesions in rheumatoid arthritis. — Ann. intern, med., 1957, 46, 831.
Kettel L. J., Morse J. O. In Azarnoff (Ed.) Steroid Therapy, p 293. Saunders, Philadelphia, 1975.
Klinenberg J. R., Miller R. Effect of cortico steroids on blood salicylate concentrations. — J. A. M. A., 1965, 194, 601.
Leading Article: Corticosteroids and hypothalamic-pituitary-adrenocortical function. — Brit. med. J., 1980, 280, 813.
Lewis G. P., Jusko W. J., Burke C. W. et al. Prednisone side effects and serum protein levels. — Lancet, 1971, 2, 778.
Lewis G. P., Piper P. J. Inhibition of release of prostaglandins as an explanation of some of the actions of anti-inflammatory corticosteroids. — Nature, 1975, 254, 308.
Madsbad S., Bjerregaard В., Henriksen J, H. et al. Impaired conversion of prednisone to prednisolone in patients with liver conditions. — Gut, 1980, 21,
Marble A., Selenkow H. A., Rose L. I. et al. Endocrine disease; in Avery (Ed ) Drug Treatment, p. 530. Adis Press, Sydney, 1980.
Mills I. H., Schedl H. P., Chen P. S., Bartter F. C. The effect of estrogen administration on the metabolism and protein binding of hydrocortisone — J. clin. Endocrinol. Metabol, 1960, 20, 515.
Myles А. В., Bacon P. A., Daly J. R. Single daily dose corticosteroid treatment-Effect on adrenal function and therapeutic efficacy in various diseases. — Ann. rheumat. Dis., 1971, 30, 149.
Newcome D. S., Ishikawa Y. Effect of anti-inflammatory agents on human synovial fibroblast prostaglandin synthetase. — Prostaglandins, 1976, 12, 849.
Oyama T. Hazards of steroids in association with anaesthesia. — Canad Anaesthetics Society Journal, 1969, 16, 361.
Popert A. J. Personal communication, 1976.
Powell L. W. et al. Corticosteroids in liver disease: Studies on the biological conversion of prednisone to prednisolone and plasma protein binding — Gut, 1972, 13, 690.
Salassa R. M., Bennett W. A., Keatting Jnr. F. R., Sprangne R. G. Postoperative adrenal cortical insufficiency occurrence in patients previously treated with cortisone. — J. A. M. A., 1953, 152, 1509.
Stjernholm M. R., Katz F. H. Effect of diphenylhydantoin, phenobarbital, and diazepam on the metabolism of methyl-prednisolone and its sodium succinate. — J. clin. Endocrinol. Metabol., 1975, 41, 887.
Warrell D. W., Taylor R. Outcome for the foetus of mothers receiving prednisolone during pregnancy. — Lancet, 1968, 1, 117.
Weissman G., Thomas R. Recent Progress in Hormone. — Research 1968, 20. 215.
Werk E. E., Choi Y., Sholiton L. et al. Interference in the effect of dexamethasone by diphenylhydantoin. — New Engl. J. Med., 1969, 281, 32.
Werk E. E., MacGee J., Sholiton L. J. Effect of diphenylhydantoin on cortison metabolism in man. — J. clin. Investigation, 1964, 43, 1824.
Wilson J. G. Present states of teratogens in man. — Teratology, 1973, 7, 3.
Yackel D. S., Kempers R. D., McConahey W. M. Arenocorticosteroid therapy in .-pregnancy. — Amer. J. Obstet. Gynec, 1966, 96, 985.
Yonnt W. J., Utsinger P. D., Hadler N. M., Gammon W. R. In. Azarnoff (Ed.) Steroid Therapy, p. 271, Saunders, Philadelphia, 1975.
Кортикотропин
Carter M. E., James V. H., T. An attempt at combining corticotrophin with long-term corticosteroid therapy. — Ann. rheumat. Dis„ 1970, 29, 409.
Glass D., Daly J. R. Development of antibodies during long-term therapy with corticotrophin in rheumatoid arthritis. I. Porcine ACTH. — Ann rheumat. Dis., 1971, 30, 589.
Glass D., Nuki G., Daly J. R. Development of antibodies during longterm therapy with corticotrophin in rheumatoid arthritis. II. Zinc tetracosactrin (depot synacthed). — Ann. rheumat. Dis., 1971 30, 593.
«Лечение ревматических заболеваний»,
под ред. Ф.Д.Харта
Читайте далее:
